"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
Descriptor ID |
D006086
|
MeSH Number(s) |
C20.452
|
Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 |
2004 | 1 | 1 | 2 |
2005 | 1 | 1 | 2 |
2006 | 1 | 0 | 1 |
2007 | 1 | 1 | 2 |
2008 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2012 | 0 | 2 | 2 |
2013 | 0 | 1 | 1 |
2014 | 1 | 1 | 2 |
2015 | 2 | 2 | 4 |
2016 | 2 | 1 | 3 |
2017 | 34 | 38 | 72 |
2018 | 32 | 28 | 60 |
2019 | 16 | 13 | 29 |
2020 | 3 | 0 | 3 |
2021 | 4 | 2 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
Acute graft-versus-host disease after liver transplantation in a close contact with COVID-19: A case report. Transpl Immunol. 2021 10; 68:101435.
-
Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic? Bone Marrow Transplant. 2021 10; 56(10):2489-2496.
-
Graft-versus-host disease-like reactions in the gastrointestinal tract in a patient with SARS-CoV-2 infection. Dig Endosc. 2021 Jul; 33(5):876-877.
-
Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Transl Med. 2021 09; 10(9):1288-1303.
-
Clinical Effects of COVID-19 on Hematopoietic Stem Cell Transplant Outcomes in Pediatric Patients. Exp Clin Transplant. 2021 05; 19(5):501-507.
-
Successful Salvage Haploidentical Bone Marrow Transplantation in a Child With Hemophagocytic Lymphohistiocytosis, When the Previously Matched Unrelated Donor Tested Positive for SARS-CoV-2 on the Day of Stem Cells Collection. Transplant Proc. 2021 Oct; 53(8):2498-2501.
-
47th Annual Meeting of the EBMT. Lancet Haematol. 2021 05; 8(5):e317-e318.
-
Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature. World J Gastroenterol. 2021 Mar 14; 27(10):928-938.
-
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHD. Transpl Infect Dis. 2021 Aug; 23(4):e13576.
-
Clinical Challenges in an Unusual Setting: ST-Elevation in a Patient Suffering From Graft Versus Host Disease, Between Thrombosis and Coronary Spasm. Cardiovasc Revasc Med. 2021 07; 28S:239-242.